JonesTrading Downgrades Theratechnologies(THTX.US) to Hold Rating
Theratechnologies (THTX) Was Downgraded to a Hold Rating at JonesTrading
Theratechnologies: Strong Q2 Performance and Positive Outlook Justify Buy Rating
Theratechnologies (THTX) Gets a Buy From JonesTrading
Analysts Offer Insights on Healthcare Companies: Theratechnologies (THTX), MoonLake Immunotherapeutics (MLTX) and DENTSPLY SIRONA (XRAY)
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Argenx Se (ARGX) and Theratechnologies (THTX)
Theratechnologies Receives Buy Rating: Expected Capital Raise and R&D Strategy Shift to Boost Performance
National Bank Reviews Theratechnologies' Q3 Results, Cuts Price Target to $5.50, Reiterates Sector Perform
Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and Theratechnologies (THTX)
Theratechnologies Price Target Updated to $7 at National Bank Following Share Consolidation
JonesTrading Adjusts Price Target on Theratechnologies to $3 From $6, Maintains Buy Rating
JonesTrading Maintains Buy on Theratechnologies, Lowers Price Target to $3
Theratechnologies Analyst Ratings
National Bank Reaffirms Their Hold Rating on Theratechnologies (THTX)
Theratechnologies Analyst Ratings
National Bank Cuts Theratechnologies' Price Target to $1.75, Maintains Sector Perform, After Q2 Miss
Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2
Theratechnologies (THTX) Receives a Buy From JonesTrading
Theratechnologies (THTX) Gets a Buy From JonesTrading
JonesTrading Sticks to Their Buy Rating for Theratechnologies (THTX)
No Data